Clinical trial

A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the…

NCT00293891 · Astellas Pharma Inc, Industry · Completed

Key facts

NCT number NCT00293891
Title A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of Psoriasis
Lead sponsor Astellas Pharma Inc, Industry
Collaborators Astellas Pharma US, Inc. Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Psoriasis
Intervention type Drug
Interventions Tacrolimus Cream
Enrollment 658
Completion Jan 1, 2007
First posted Feb 20, 2006
Last update posted Dec 24, 2007
Countries Canada, United States

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies